Literature DB >> 27669574

Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles.

Sabrina Lusvarghi1, Katheryn Lohith1, Jeanne Morin-Leisk1, Rodolfo Ghirlando1, Jenny E Hinshaw1, Carole A Bewley1.   

Abstract

Carbohydrate binding proteins such as griffithsin, cyanovirin-N, and BanLec are potent HIV entry inhibitors and promising microbicides. Each binds to high-mannose glycans on the surface envelope glycoprotein gp120, yet the mechanisms by which they engage viral spikes and exhibit inhibition constants ranging from nanomolar to picomolar are not understood. To determine the structural and mechanistic basis for recognition and potency, we selected a panel of lectins possessing different valencies per subunit, oligomeric states, and relative orientations of carbohydrate binding sites to systematically probe their contributions to inhibiting viral entry. Cryo-electron micrographs and immuno gold staining of lectin-treated viral particles revealed two distinct effects-namely, viral aggregation or clustering of the HIV-1 envelope on the viral membrane-that were dictated by carbohydrate binding site geometry and valency. "Sandwich" surface plasmon resonance experiments revealed that a second binding event occurs only for those lectins that could aggregate viral particles. Furthermore, picomolar Kd values were observed for the second binding event, providing a mechanism by which picomolar IC50 values are achieved. We suggest that these binding and aggregation phenomena translate to neutralization potency.

Entities:  

Keywords:  HIV gp120 (gp120); cryo-electron microscopy (cryo-EM); electron microscopy (EM); envelope glycoprotein; multivalency; surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2016        PMID: 27669574      PMCID: PMC7261407          DOI: 10.1021/acsinfecdis.6b00139

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  43 in total

1.  Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV.

Authors:  Jan Balzarini; Kristel Van Laethem; Sigrid Hatse; Matheus Froeyen; Willy Peumans; Els Van Damme; Dominique Schols
Journal:  J Biol Chem       Date:  2005-09-23       Impact factor: 5.157

2.  Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.

Authors:  Jason S McLellan; Marie Pancera; Chris Carrico; Jason Gorman; Jean-Philippe Julien; Reza Khayat; Robert Louder; Robert Pejchal; Mallika Sastry; Kaifan Dai; Sijy O'Dell; Nikita Patel; Syed Shahzad-ul-Hussan; Yongping Yang; Baoshan Zhang; Tongqing Zhou; Jiang Zhu; Jeffrey C Boyington; Gwo-Yu Chuang; Devan Diwanji; Ivelin Georgiev; Young Do Kwon; Doyung Lee; Mark K Louder; Stephanie Moquin; Stephen D Schmidt; Zhi-Yong Yang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Dennis R Burton; Wayne C Koff; Laura M Walker; Sanjay Phogat; Richard Wyatt; Jared Orwenyo; Lai-Xi Wang; James Arthos; Carole A Bewley; John R Mascola; Gary J Nabel; William R Schief; Andrew B Ward; Ian A Wilson; Peter D Kwong
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

3.  Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

Authors:  Daniel A Calarese; Hing-Ken Lee; Cheng-Yuan Huang; Michael D Best; Rena D Astronomo; Robyn L Stanfield; Hermann Katinger; Dennis R Burton; Chi-Huey Wong; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-07       Impact factor: 11.205

4.  Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

Authors:  Kabamba B Alexandre; Penny L Moore; Molati Nonyane; Elin S Gray; Nthabeleng Ranchobe; Ereck Chakauya; James B McMahon; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2013-08-15       Impact factor: 3.616

5.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

6.  A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.

Authors:  Robert Pejchal; Katie J Doores; Laura M Walker; Reza Khayat; Po-Ssu Huang; Sheng-Kai Wang; Robyn L Stanfield; Jean-Philippe Julien; Alejandra Ramos; Max Crispin; Rafael Depetris; Umesh Katpally; Andre Marozsan; Albert Cupo; Sebastien Maloveste; Yan Liu; Ryan McBride; Yukishige Ito; Rogier W Sanders; Cassandra Ogohara; James C Paulson; Ten Feizi; Christopher N Scanlan; Chi-Huey Wong; John P Moore; William C Olson; Andrew B Ward; Pascal Poignard; William R Schief; Dennis R Burton; Ian A Wilson
Journal:  Science       Date:  2011-10-13       Impact factor: 47.728

7.  Molecular architecture of native HIV-1 gp120 trimers.

Authors:  Jun Liu; Alberto Bartesaghi; Mario J Borgnia; Guillermo Sapiro; Sriram Subramaniam
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

8.  A lectin isolated from bananas is a potent inhibitor of HIV replication.

Authors:  Michael D Swanson; Harry C Winter; Irwin J Goldstein; David M Markovitz
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

9.  Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate.

Authors:  Joseph Calvin Kouokam; Dana Huskens; Dominique Schols; Andrew Johannemann; Shonna K Riedell; Wendye Walter; Janice M Walker; Nobuyuki Matoba; Barry R O'Keefe; Kenneth E Palmer
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

10.  Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus.

Authors:  Tinoush Moulaei; Kabamba B Alexandre; Shilpa R Shenoy; Joel R Meyerson; Lauren Rh Krumpe; Brian Constantine; Jennifer Wilson; Robert W Buckheit; James B McMahon; Sriram Subramaniam; Alexander Wlodawer; Barry R O'Keefe
Journal:  Retrovirology       Date:  2015-01-23       Impact factor: 4.602

View more
  11 in total

1.  Chemical and Biophysical Approaches for Complete Characterization of Lectin-Carbohydrate Interactions.

Authors:  Sabrina Lusvarghi; Rodolfo Ghirlando; Jack R Davison; Carole A Bewley
Journal:  Methods Enzymol       Date:  2017-07-23       Impact factor: 1.600

2.  Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.

Authors:  Kathryn Fischer; Kimberly Nguyen; Patricia J LiWang
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  Quantitative mass imaging of single biological macromolecules.

Authors:  Gavin Young; Nikolas Hundt; Daniel Cole; Adam Fineberg; Joanna Andrecka; Andrew Tyler; Anna Olerinyova; Ayla Ansari; Erik G Marklund; Miranda P Collier; Shane A Chandler; Olga Tkachenko; Joel Allen; Max Crispin; Neil Billington; Yasuharu Takagi; James R Sellers; Cédric Eichmann; Philipp Selenko; Lukas Frey; Roland Riek; Martin R Galpin; Weston B Struwe; Justin L P Benesch; Philipp Kukura
Journal:  Science       Date:  2018-04-27       Impact factor: 47.728

4.  Structure and Carbohydrate Recognition by the Nonmitogenic Lectin Horcolin.

Authors:  Vaishali Narayanan; Kishore Babu Bobbili; Nukathoti Sivaji; Nisha G Jayaprakash; Kaza Suguna; Avadhesha Surolia; Ashok Sekhar
Journal:  Biochemistry       Date:  2022-02-28       Impact factor: 3.321

5.  Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.

Authors:  Bibek Parajuli; Kriti Acharya; Harry C Bach; Bijay Parajuli; Shiyu Zhang; Amos B Smith; Cameron F Abrams; Irwin Chaiken
Journal:  Biochem J       Date:  2018-03-09       Impact factor: 3.857

Review 6.  Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.

Authors:  Sabrina Lusvarghi; Carole A Bewley
Journal:  Viruses       Date:  2016-10-24       Impact factor: 5.048

7.  Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins.

Authors:  Muzafar Jan; Chitra Upadhyay; José Alcami Pertejo; Catarina E Hioe; Sunil K Arora
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

Review 8.  An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors:  Hajie Lotfi; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Bioimpacts       Date:  2017-11-16

Review 9.  Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application.

Authors:  Choongho Lee
Journal:  Mar Drugs       Date:  2019-10-06       Impact factor: 5.118

10.  The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans.

Authors:  Jonathan T S Hopper; Stephen Ambrose; Oliver C Grant; Stefanie A Krumm; Timothy M Allison; Matteo T Degiacomi; Mark D Tully; Laura K Pritchard; Gabriel Ozorowski; Andrew B Ward; Max Crispin; Katie J Doores; Robert J Woods; Justin L P Benesch; Carol V Robinson; Weston B Struwe
Journal:  Structure       Date:  2017-04-20       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.